We speculated that PSPH‐mediated NSCLC cell progression and aggressiveness might be at least partly attributed to the activation of the AKT/AMPK signaling pathway, which is critical for the initiation and progression of NSCLC. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.